Fas mediates cardiac allograft acceptance in mice with impaired T-cell-intrinsic NF-κB signaling

Transplant International

Volumn 22, Issue 8, 2009, Pages 845-852

  Molinero, Luciana Lorena ^a   Wang, Ying ^a   Zhou, Ping ^b   Yagita, Hideo ^c   Alegre, Maria Luisa ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b Tongji Hospital   (China)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Fas; Mouse; NF B; T cells; Tolerance; Transplantation

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL XL; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CONTROLLED STUDY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSTIMULATION; IN VITRO STUDY; INTERFERON PRODUCTION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SKIN ALLOGRAFT; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TRANSPLANTATION TOLERANCE; WILD TYPE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; GRAFT REJECTION; HEART TRANSPLANTATION; I-KAPPA B PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-KAPPA B; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 67651154525     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00875.x     Document Type: Article

References (38)

1. Alegre ML. Targeting NF-kB in the immune system to prevent acute allograft rejection. Curr Opin Organ Transplant 2004 9 : 252.
2. Boothby MR, Mora AL, Scherer DC, et al. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. J Exp Med 1997 185 : 1897.
3. Aronica MA, Mora AL, Mitchell DB, et al. Preferential role for NF-kappa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. J Immunol 1999 163 : 5116.
4. Hettmann T, DiDonato J, Karin M, et al. An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. J Exp Med 1999 189 : 145.
5. Mora AL, Corn RA, Stanic AK, et al. Antiapoptotic function of NF-kappaB in T lymphocytes is influenced by their differentiation status: roles of Fas, c-FLIP, and Bcl-xL. Cell Death Differ 2003 10 : 1032.
6. Seetharaman R, Mora AL, Nabozny G, et al. Essential role of T cell NF-kappa B activation in collagen-induced arthritis. J Immunol 1999 163 : 1577.
7. Tato CM, Villarino A, Caamano JH, et al. Inhibition of NF-kappa B activity in T and NK cells results in defective effector cell expansion and production of IFN-gamma required for resistance to Toxoplasma gondii. J Immunol 2003 170 : 3139.
8. Zhou P, Hwang KW, Palucki DA, et al. Impaired NF-kB activation in T cells permits tolerance to primary heart allografts and to secondary donor skin grafts. Am J Transplant 2003 3 : 139.
9. Zhou P, Balin SJ, Mashayekhi M, et al. Transplantation tolerance in NF-kappaB-impaired mice is not due to regulation but is prevented by transgenic expression of Bcl-xL. J Immunol 2005 174 : 3447.
10. Molinero L, Zhou P, Wang Y, et al. Epidermal Langerhans cells play a major role in skin allograft rejection in mice with NF-kB-impaired T cells. Am J Transplant 2008 8 : 21.
11. Zhou T, Mountz JD, Kimberly RP. Immunobiology of tumor necrosis factor receptor superfamily. Immunol Res 2002 26 : 323.
12. Thorburn A. Death receptor-induced cell killing. Cell Signal 2004 16 : 139.
13. Legembre P, Barnhart BC, Zheng L, et al. Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholds. EMBO Rep 2004 5 : 1084.
14. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973 16 : 343.
15. Sica A, Dorman L, Viggiano V, et al. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J Biol Chem 1997 272 : 30412.
16. Stehlik C, de Martin R, Kumabashiri I, et al. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med 1998 188 : 211.
17. Chu ZL, McKinsey TA, Liu L, et al. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci U S A 1997 94 : 10057.
18. Tamatani M, Che YH, Matsuzaki H, et al. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem 1999 274 : 8531.
19. Song J, So T, Croft M. Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival. J Immunol 2008 180 : 7240.
20. Billingham RE, Brent L, Medawar PB. Activity acquired tolerance to foreign cells. Nature 1953 172 : 602.
21. Wekerle T, Sykes M. Mixed chimerism as an approach for the induction of transplantation tolerance. Transplantation 1999 68 : 459.
22. Wells AD, Li XC, Li Y, et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 1999 5 : 1303.
23. Lehnert AM, Murray-Segal L, Cowan PJ, et al. Blockade of the passive cell death pathway does not prevent tolerance induction to islet grafts. Transplantation 2007 83 : 653.
24. Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995 270 : 1189.
25. Kang SM, Schneider DB, Lin Z, et al. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med 1997 3 : 738.
26. Xie GH, Wang SJ, Wang Y, et al. Fas Ligand gene transfer enhances the survival of tissue-engineered chondrocyte allografts in mini-pigs. Transpl Immunol 2008 19 : 145.
27. Yolcu ES, Gu X, Lacelle C, et al. Induction of tolerance to cardiac allografts using donor splenocytes engineered to display on their surface an exogenous fas ligand protein. J Immunol 2008 181 : 931.
28. Schutz C, Fleck M, Mackensen A, et al. Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells. Blood 2008 111 : 3546.
29. Holtzman MJ, Green JM, Jayaraman S, et al. Regulation of T cell apoptosis. Apoptosis 2000 5 : 459.
30. Li X, McKinstry KK, Swain SL, et al. IFN-gamma acts directly on activated CD4+ T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals. J Immunol 2007 179 : 939.
31. Ren X, Ye F, Jiang Z, et al. Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells. Cell Death Differ 2007 14 : 2076.
32. Zhang X, Brunner T, Carter L, et al. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 1997 185 : 1837.
33. Corn RA, Aronica MA, Zhang F, et al. T cell-intrinsic requirement for NF-kappa B induction in postdifferentiation IFN-gamma production and clonal expansion in a Th1 response. J Immunol 2003 171 : 1816.
34. Choi JH, Do Y, Cheong C, et al. Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J Exp Med 2009 16 : 16.
35. Pietra BA, Wiseman A, Bolwerk A, et al. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest 2000 106 : 1003.
36. Szot GL, Zhou P, Rulifson I, et al. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am J Transplant 2001 1 : 38.
37. Sleater M, Diamond AS, Gill RG. Islet allograft rejection by contact-dependent CD8+ T cells: perforin and FasL play alternate but obligatory roles. Am J Transplant 2007 7 : 1927.
38. Wagener ME, Konieczny BT, Dai Z, et al. Alloantigen-driven T cell death mediated by Fas ligand and tumor necrosis factor-alpha is not essential for the induction of allograft acceptance. Transplantation 2000 69 : 2428.